Cargando…

Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer's disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells

Detalles Bibliográficos
Autores principales: Harmening, Kathrin, Heile, Anna, Miller, Miles, Johanson, Conrad E, Wallrapp, Christine, Brinker, Thomas, Silverberg, Gerald D, Klinge, Petra M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786122/
http://dx.doi.org/10.1186/1743-8454-6-S2-S15
_version_ 1782174864377905152
author Harmening, Kathrin
Heile, Anna
Miller, Miles
Johanson, Conrad E
Wallrapp, Christine
Brinker, Thomas
Silverberg, Gerald D
Klinge, Petra M
author_facet Harmening, Kathrin
Heile, Anna
Miller, Miles
Johanson, Conrad E
Wallrapp, Christine
Brinker, Thomas
Silverberg, Gerald D
Klinge, Petra M
author_sort Harmening, Kathrin
collection PubMed
description
format Text
id pubmed-2786122
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27861222009-12-02 Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer's disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells Harmening, Kathrin Heile, Anna Miller, Miles Johanson, Conrad E Wallrapp, Christine Brinker, Thomas Silverberg, Gerald D Klinge, Petra M Cerebrospinal Fluid Res Oral Presentation BioMed Central 2009-11-27 /pmc/articles/PMC2786122/ http://dx.doi.org/10.1186/1743-8454-6-S2-S15 Text en Copyright ©2009 Harmening et al; licensee BioMed Central Ltd.
spellingShingle Oral Presentation
Harmening, Kathrin
Heile, Anna
Miller, Miles
Johanson, Conrad E
Wallrapp, Christine
Brinker, Thomas
Silverberg, Gerald D
Klinge, Petra M
Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer's disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells
title Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer's disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells
title_full Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer's disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells
title_fullStr Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer's disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells
title_full_unstemmed Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer's disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells
title_short Microglial downregulation in a double transgenic mouse model associated with early-onset Alzheimer's disease (AD) after intraventricular implantation of alginate encapsulated Glukagon-like-peptide-1 (GLP-1) producing human mesenchymal stem-cells
title_sort microglial downregulation in a double transgenic mouse model associated with early-onset alzheimer's disease (ad) after intraventricular implantation of alginate encapsulated glukagon-like-peptide-1 (glp-1) producing human mesenchymal stem-cells
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2786122/
http://dx.doi.org/10.1186/1743-8454-6-S2-S15
work_keys_str_mv AT harmeningkathrin microglialdownregulationinadoubletransgenicmousemodelassociatedwithearlyonsetalzheimersdiseaseadafterintraventricularimplantationofalginateencapsulatedglukagonlikepeptide1glp1producinghumanmesenchymalstemcells
AT heileanna microglialdownregulationinadoubletransgenicmousemodelassociatedwithearlyonsetalzheimersdiseaseadafterintraventricularimplantationofalginateencapsulatedglukagonlikepeptide1glp1producinghumanmesenchymalstemcells
AT millermiles microglialdownregulationinadoubletransgenicmousemodelassociatedwithearlyonsetalzheimersdiseaseadafterintraventricularimplantationofalginateencapsulatedglukagonlikepeptide1glp1producinghumanmesenchymalstemcells
AT johansonconrade microglialdownregulationinadoubletransgenicmousemodelassociatedwithearlyonsetalzheimersdiseaseadafterintraventricularimplantationofalginateencapsulatedglukagonlikepeptide1glp1producinghumanmesenchymalstemcells
AT wallrappchristine microglialdownregulationinadoubletransgenicmousemodelassociatedwithearlyonsetalzheimersdiseaseadafterintraventricularimplantationofalginateencapsulatedglukagonlikepeptide1glp1producinghumanmesenchymalstemcells
AT brinkerthomas microglialdownregulationinadoubletransgenicmousemodelassociatedwithearlyonsetalzheimersdiseaseadafterintraventricularimplantationofalginateencapsulatedglukagonlikepeptide1glp1producinghumanmesenchymalstemcells
AT silverberggeraldd microglialdownregulationinadoubletransgenicmousemodelassociatedwithearlyonsetalzheimersdiseaseadafterintraventricularimplantationofalginateencapsulatedglukagonlikepeptide1glp1producinghumanmesenchymalstemcells
AT klingepetram microglialdownregulationinadoubletransgenicmousemodelassociatedwithearlyonsetalzheimersdiseaseadafterintraventricularimplantationofalginateencapsulatedglukagonlikepeptide1glp1producinghumanmesenchymalstemcells